Merck & Co., Inc.MRKNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+21.3%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+21.3%/yr
vs +78.6%/yr prior
Acceleration
-57.3pp
Decelerating
Percentile
P93
Near historical high
vs 3Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 5.05% |
| 2024 | 2.19% |
| 2023 | 2.22% |
| 2022 | 2.83% |
| 2021 | 9.73% |
| 2020 | -9.37% |
| 2019 | -6.40% |
| 2018 | 0.28% |
| 2017 | 0.57% |
| 2016 | -2.87% |